Public Policy Committee

BioNJ’s Public Policy Committee serves as an important sounding board for BioNJ’s public policy efforts. The committee is comprised of executive and policy leadership in New Jersey’s life sciences innovation sector, from CEOs to government relations personnel and others. The committee meets regularly to provide BioNJ with feedback on policy machinations in Trenton and beyond; while participating in monthly update calls with BioNJ staff. Committee members frequently hear from guest speakers, including legislators, administrative and regulatory leaders, and others in the life sciences community at committee meetings, events and receptions.

Committee Members

AbbVie – Joseph Oros, Director, State Government Affairs
Adastra Pharmaceuticals, Inc. – Scott Megaffin, CEO
Amgen, Inc. – Andrew Marocco, Director, State Government Affairs
Amicus Therapeutics, Inc. – Paul Howard, Director, Public Policy
AzurRx BioPharma – James Sapirstein, MBA, RPh, President and CEO
Bayesian Biotech – John Maki, CEO
BIO – Ben Chandok, State Government Affairs, Eastern Region
Biogen – Angela Gochenaur, Director, State Government Affairs
Bristol-Myers Squibb Company – Ethan Hasbrouck, MPA, State Government Affairs
Eli Lilly & Company – Timothy Lyden, Director, State Government and Business Affairs
Ferring Pharmaceuticals, Inc. – Lillian German, Director, Government Affairs
Ferring Pharmaceuticals, Inc. – Joseph Zimmerman, Vice President – Chief Compliance & Privacy Officer, U.S.
Gamida Cell – Michele Korfin, MBA, Chief Operating Officer & Chief Commercial Officer
Genmab – Christine Zettlemoyer, Head of Global Compliance
Gilead – Sherri Giorgio, Director, State Government Affairs
GlaxoSmithKline –Paul Madrazo, Director, State Government Affairs
Greenwich Biosciences – Jan Burrus, Government Affairs Director
Horizon Therapeutics – Liz Pujolas, Director, State Government Affairs & Policy
Ipsen US – Francis Rienzo, Head, State Government Affairs & Policy
J&J – Chris Guiton, JD, Senior Director, US State Government Affairs
Kyowa Kirin – Lauren Walrath, Head of Public Affairs
Merck & Co., Inc. – Domenick Argento, Associate Director, Account Management, Government Affairs & Policy
Novartis Pharmaceuticals – Leigh Ann Leas, VP and North America Head, Public Policy
Novartis Pharmaceuticals – Candie Phipps, Director, State Government and Business Affairs
Novo Nordisk – Kate Barry, Associate Director, State Government Affairs
OncoSec Medical Inc. – Daniel O’Connor, JD, CEO
OncoSTING – Ambaw Bellete, President and Chair of Public Policy Committee
Otsuka America Pharmaceutical – Patrick Stone, Associate Director for State Government Affairs, Mid-Atlantic Region
Pfizer – Anna Maria Maritato, Senior Director, State Government Relations
PTC Therapeutics, Inc. – Theodore Piper, Associate Director, State Government Affairs
Rigby Consulting, LLC – Kevin Rigby, JD, Principal
Sanofi – George Coutros, Director, State Government Affairs
Soligenix, Inc. – Dennis Ondrejik, Program Manager
Translatum Medicus, Inc. – Paul Howes MBA, Executive Vice President
Vertex Pharmaceuticals – Martha Auster, Regional Director, Government Affairs